These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25931779)

  • 1. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.
    Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell experiments moves into clinic: new hope for children with bronchopulmonary dysplasia.
    Pawelec K; Gładysz D; Demkow U; Boruczkowski D
    Adv Exp Med Biol; 2015; 839():47-53. PubMed ID: 25252892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of stem cells in bronchopulmonary dysplasia.
    O'Reilly M; Thébaud B
    Semin Perinatol; 2013 Apr; 37(2):79-84. PubMed ID: 23582961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils.
    Möbius MA; Thébaud B
    Paediatr Respir Rev; 2016 Sep; 20():33-41. PubMed ID: 27425012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stromal Cell-Based Therapies for Chronic Lung Disease of Prematurity.
    Strueby L; Thébaud B
    Am J Perinatol; 2016 Sep; 33(11):1043-9. PubMed ID: 27603532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy.
    Pierro M; Ciarmoli E; Thébaud B
    Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based therapies for neonatal lung disease.
    O'Reilly M; Thébaud B
    Cell Tissue Res; 2017 Mar; 367(3):737-745. PubMed ID: 27770256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: "It's About Time" or "Not so Fast" ?
    Ee MT; Thébaud B
    Curr Pediatr Rev; 2018; 14(4):227-238. PubMed ID: 30205800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells for the prevention of neonatal lung disease.
    O'Reilly M; Thébaud B
    Neonatology; 2015; 107(4):360-4. PubMed ID: 26044105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based therapy for bronchopulmonary dysplasia in preterm infants
    Guillot M; Offringa M; Lacaze-Masmonteil T; Thébaud B
    Can J Physiol Pharmacol; 2019 Mar; 97(3):232-234. PubMed ID: 30290122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchopulmonary dysplasia: structural challenges and stem cell treatment potential.
    Niver D
    Adv Neonatal Care; 2014 Feb; 14(1):E1-E11. PubMed ID: 24472891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review.
    Simones AA; Beisang DJ; Panoskaltsis-Mortari A; Roberts KD
    Pediatr Res; 2018 Jan; 83(1-2):308-317. PubMed ID: 28945702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mesenchymal stem cell transplantation in the treatment of bronchopulmonary dysplasia: opportunities and challenges].
    Bao L; Shi Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):619-623. PubMed ID: 31315757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.
    Pierro M; Thébaud B; Soll R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011932. PubMed ID: 29125893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile.
    Álvarez-Fuente M; Arruza L; Lopez-Ortego P; Moreno L; Ramírez-Orellana M; Labrandero C; González Á; Melen G; Cerro MJD
    Cytotherapy; 2018 Nov; 20(11):1337-1344. PubMed ID: 30327248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells and Bronchopulmonary Dysplasia - The five questions: Which cells, when, in which dose, to which patients via which route?
    Mueller M; Kramer BW
    Paediatr Respir Rev; 2017 Sep; 24():54-59. PubMed ID: 28162941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study.
    Lim R; Malhotra A; Tan J; Chan ST; Lau S; Zhu D; Mockler JC; Wallace EM
    Stem Cells Transl Med; 2018 Sep; 7(9):628-635. PubMed ID: 30078207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.
    Lesage F; Thébaud B
    Semin Perinatol; 2018 Nov; 42(7):453-458. PubMed ID: 30376986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.